Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing.

Ishihara J, Ishihara A, Starke RD, Peghaire CR, Smith KE, McKinnon TAJ, Tabata Y, Sasaki K, White MJV, Fukunaga K, Laffan MA, Lutolf MP, Randi AM, Hubbell JA.

Blood. 2019 Jun 13;133(24):2559-2569. doi: 10.1182/blood.2019000510. Epub 2019 Apr 11.

PMID:
30975637
2.

Downregulation of MicroRNA-126 Augments DNA Damage Response in Cigarette Smokers and Patients with Chronic Obstructive Pulmonary Disease.

Paschalaki KE, Zampetaki A, Baker JR, Birrell MA, Starke RD, Belvisi MG, Donnelly LE, Mayr M, Randi AM, Barnes PJ.

Am J Respir Crit Care Med. 2018 Mar 1;197(5):665-668. doi: 10.1164/rccm.201706-1304LE. No abstract available.

3.

An autologous endothelial cell:peripheral blood mononuclear cell assay that detects cytokine storm responses to biologics.

Reed DM, Paschalaki KE, Starke RD, Mohamed NA, Sharp G, Fox B, Eastwood D, Bristow A, Ball C, Vessillier S, Hansel TT, Thorpe SJ, Randi AM, Stebbings R, Mitchell JA.

FASEB J. 2015 Jun;29(6):2595-602. doi: 10.1096/fj.14-268144. Epub 2015 Mar 6.

PMID:
25746794
4.

Von Willebrand factor, angiodysplasia and angiogenesis.

Randi AM, Laffan MA, Starke RD.

Mediterr J Hematol Infect Dis. 2013 Sep 2;5(1):e2013060. doi: 10.4084/MJHID.2013.060. Review.

5.

Dysfunction of endothelial progenitor cells from smokers and chronic obstructive pulmonary disease patients due to increased DNA damage and senescence.

Paschalaki KE, Starke RD, Hu Y, Mercado N, Margariti A, Gorgoulis VG, Randi AM, Barnes PJ.

Stem Cells. 2013 Dec;31(12):2813-26. doi: 10.1002/stem.1488.

6.

Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells.

Starke RD, Paschalaki KE, Dyer CE, Harrison-Lavoie KJ, Cutler JA, McKinnon TA, Millar CM, Cutler DF, Laffan MA, Randi AM.

Blood. 2013 Apr 4;121(14):2773-84. doi: 10.1182/blood-2012-06-435727. Epub 2013 Jan 25.

7.

Endothelial von Willebrand factor regulates angiogenesis.

Starke RD, Ferraro F, Paschalaki KE, Dryden NH, McKinnon TA, Sutton RE, Payne EM, Haskard DO, Hughes AD, Cutler DF, Laffan MA, Randi AM.

Blood. 2011 Jan 20;117(3):1071-80. doi: 10.1182/blood-2010-01-264507. Epub 2010 Nov 3.

8.

Gamma-glutamyl transferase: a novel cardiovascular risk biomarker.

Mason JE, Starke RD, Van Kirk JE.

Prev Cardiol. 2010 Winter;13(1):36-41. doi: 10.1111/j.1751-7141.2009.00054.x. Review.

9.

The VWF/ADAMTS13 axis in the antiphospholipid syndrome: ADAMTS13 antibodies and ADAMTS13 dysfunction.

Austin SK, Starke RD, Lawrie AS, Cohen H, Machin SJ, Mackie IJ.

Br J Haematol. 2008 May;141(4):536-44. doi: 10.1111/j.1365-2141.2008.07074.x. Epub 2008 Mar 12.

PMID:
18341632
10.

Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura.

Camilleri RS, Cohen H, Mackie IJ, Scully M, Starke RD, Crawley JT, Lane DA, Machin SJ.

J Thromb Haemost. 2008 Feb;6(2):331-8. Epub 2007 Nov 20.

11.

AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.

Smith SC Jr, Blair SN, Bonow RO, Brass LM, Cerqueira MD, Dracup K, Fuster V, Gotto A, Grundy SM, Miller NH, Jacobs A, Jones D, Krauss RM, Mosca L, Ockene I, Pasternak RC, Pearson T, Pfeffer MA, Starke RD, Taubert KA.

J Am Coll Cardiol. 2001 Nov 1;38(5):1581-3. No abstract available.

12.

AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.

Smith SC Jr, Blair SN, Bonow RO, Brass LM, Cerqueira MD, Dracup K, Fuster V, Gotto A, Grundy SM, Miller NH, Jacobs A, Jones D, Krauss RM, Mosca L, Ockene I, Pasternak RC, Pearson T, Pfeffer MA, Starke RD, Taubert KA.

Circulation. 2001 Sep 25;104(13):1577-9. No abstract available.

PMID:
11571256
13.

Recommendations for the establishment of primary stroke centers. Brain Attack Coalition.

Alberts MJ, Hademenos G, Latchaw RE, Jagoda A, Marler JR, Mayberg MR, Starke RD, Todd HW, Viste KM, Girgus M, Shephard T, Emr M, Shwayder P, Walker MD.

JAMA. 2000 Jun 21;283(23):3102-9. Review.

PMID:
10865305
14.

Preventing heart attack and death in patients with coronary disease. Endorsed by the board of trustees of the American College of Cardiology.

Smith SC Jr, Blair SN, Criqui MH, Fletcher GF, Fuster V, Gersh BJ, Gotto AM, Gould KL, Greenland P, Grundy SM, Hill MN, Hlatky MA, Houston-Miller N, Krauss RM, LaRosa J, Ockene IS, Oparil S, Pearson TA, Rapaport E, Starke RD.

Cardiovasc Nurs. 1996 Jul-Aug;32(4):26-8. Review. No abstract available.

PMID:
8846481
17.

Cardiac arrhythmias--diagnosis and clinical treatment.

Starke RD, Chamberlain FL, Jahn L.

Cardiovasc Nurs. 1965 Fall;1(4):15-8. No abstract available.

PMID:
5174893

Supplemental Content

Loading ...
Support Center